Abstract
The answer to this question is simple: spray-drying is an effective, efficient means of producing peptide/protein-loaded powders suitable for pulmonary delivery. In addition, fine powders of proteins have application in other delivery systems (e.g., implantable pumps). If the correct formulation and spray-drying conditions can be identified, then a product can be obtained with a high yield and having a large fine-particle dose. Spray-drying is therefore a realistic alternative to the widespread practice of air-jet milling used to produce powders of low molecular-weight actives for inhalation. Indeed, air-jet milling should probably be avoided with peptides or proteins, because of possible problems of physical instability and inactivation. Apart from these considerations, spray-drying is also a suitable technique for embedding sensitive peptides or proteins in stabilizing excipients (“carriers”) such as disaccharides or amino acids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler, M., and Lee, G., 1999. Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J. Pharm. Sci. 88:199.
Adler, M., Unger, M., and Lee, G., 2000. The surface composition of spray-dried trehalose/bovine serum albumin/surfactant particle. Pharm. Res. 17:863.
Andy a, J., Maa, Y., Costantino, H., Nguyen, P., Dasovich, N., Sweeney, T., Hsu, C., and Shire, S., 1999. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm. Res. 16:350.
Arakawa, T., and Timasheff, S., 1982. Stabilization of protein structures by sugars. Biochemistry 21:6536.
Branchu, S., Forbes, R., York, P., Petren, S., Nyquist, H., and Camber, O., 1999. Hydroxypropyl-β-cyclodextrin inhibits spray-drying-induced inactivation of β-galactosidase. J. Pharm. Sci. 88:905.
Broadhead, J., Rouan, S., Hau, I., and Rhodes, C., 1993. The effect of process and formulation variables on the properties of spray-dried β-galactosidase. J. Pharm. Pharmacol. 46:458.
Broadhead, J., Rouan, S., and Rhodes, C., 1992. The spray drying of pharmaceuticals. Drug Devel. Ind. Pharm. 18:1169.
Broadhead, J., Rouan, S., and Rhodes, C., 1996. The deposition of spray-dried β-galactosidase from dry powder inhaler devices. Drug Devel Ind. Pharm. 22:813.
Byron, P., Naini, V., and Phillips, E., 1996. Drug carrier selection—important physiochemical characteristics, in: Respiratory Drug Delivery V, P. Byron, P. et al. eds., Interpharm. Press, Buffalo Grove, IL.
Carpenter, J., Prestrelski, S., Anchorduguy, S., and Arakawa, T., 1994. Interactions of stabilisers with proteins during freezing and drying, in: Formulation and Delivery of Proteins, J.L. Cleland and R. Langer, eds., American Chemical Society, Washington, DC.
Chan, H., and Gonda, I., 1998. Solid state characterisation of spray-dried powders of recombinant human deoxyribonuclease. J. Pharm. Sci. 7:647.
Chang, B., Kendrick, B., and Carpenter, J., 1996. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 85:1325.
Chew, N., and Chan, H., 1999. Influence of particle size, air flow and inhaler device on the dispersion of mannitol powders as aerosols. Pharm. Res. 16:1098.
Costantino, H., Andya, J., Nguyen, P., Dasovich, N., Sweeney, T., Shire, S., Hsu, C., and Maa, Y., 1998. Effect of mannitol crystallisation on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J. Pharm. Sci. 87:1406.
Fäldt, P., and Bergenstrahl, B., 1994. The surface composition of spray-dried protein-lactose powders. Coll. Surf. A90:183.
Franks, F., Freeze-drying of bioproducts: putting principles into practice. Eur. J. Pharm. Biopharm. 45:221.
Franks, F., 1990. Freeze-drying: from empiricism to predictability. Cryo-Letters 11:93.
Frey, D., and King, C., 1986. Effect of surfactants on mass transfer during spray drying. AICHEJ 32:437.
Hancock, B., and Zografi, G., 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1.
Heller, M., Carpenter, J., and Randolph, T., 1999. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol. Bioeng. 63:167.
Hickey, A., Concessio, N., Ort, M., and Platz, R., 1994. Factors influencing the dispersion of dry powders as aerosols. Pharm. Technol. August:58.
Hiemenz, P., 1986. Principles of Colloid and Surface Chemistry, Marcel Dekker, New York.
Kajiwara, K., Franks, F., Echlin, P., and Greer, A., 1999. Structural and dynamic properties of crystalline and amorphous phases in raffinose-water mixtures. Pharm. Res. 16:1441.
Labrude, P., Rasolomanana, M., Vigneron, C., Thirion, C., and Chaillot, B., 1989. Protective effect of sucrose on spray drying of oxyhemoglobin. J. Pharm. Sci. 78:223.
Maa, Y., Costantino, H., Nguyen, P., and Hsu, C., 1997. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm. Devel. Technol. 2:213.
Maa, Y., and Hsu, C., 1997. Protein denaturation by combined effect of shear and air-liquid interface. Biotechnol. Bioeng. 54:503.
Maa, Y., Nguyen, P., Andya, J., Dasovich, N., Sweeney, T., Shire, S., and Hsu, C., 1998a. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm. Res. 15:768.
Maa, Y., Nguyen, P., and Hsu, C., 1998b. Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J. Pharm. Sci. 87:152.
Mansfield, M., 1993. A review of theories of the glass transition, in: The Glassy State in Foods, J. Blanschard and P. Lillford, eds., Nottingham University Press.
Masters, K., 1991. The Spray Drying Handbook, Longman Scientific, New York.
Mehta, D., Corbo, D., and Iqbal, K., 1996. Spray Dried Erythropoietin. International Patent WO 96/18647.
Millqvist-Fureby, A., Malmsten, M., and Bergenstahl, B., 1999. Spray-drying of trypsin— surface characterization and activity preservation. Int. J. Pharm. 188:243.
Mumenthaler, M., Hsu, C., and Pearlman, R., 1994. Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator. Pharm. Res. 11:12.
Niven, R., Lott, F., Ip., A., and Cribbs, J., 1994. Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor to the rabbit. Pharm. Res. 11:1101.
Patton, J., Foster, L., and Platz, R., 1995. Methods and compositions for pulmonary delivery of insulin. International Patent WO 95/24183.
Pikal, M., 1994. Freeze-Drying of Proteins: Process, Formulation and Stability, in: Formulation and Delivery of Proteins, J.L. Cleland and R. Langer, eds., American Chemical Society, Washington, DC.
Pikal, M., 1999. Mechanisms of protein stabilization during freeze-drying and storage: The relative importance of thermodynamic stabilization and glassy state relaxation dynamics, in: Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products, L. Rey and L.C. May, eds., Marcel Dekker, New York.
Tripp, B., Magda, J., and Andrade, J., 1995. Adsorption of globular proteins at the air/water interface as measured via dynamic surface tension: concentration dependence, mass-transfer considerations and adsorption kinetics. J. Coll. Interface Sci. 173:16.
Tzannis, S., and Prestrelski, S., 1999a. Activity-stability considerations of trypsinogen during spray-drying: effects of sucrose. J. Pharm. Sci. 88:351.
Tzannis, S., and Prestrelski, S., Moisture effects on protein-excipient interactions in spray-dried powders. Nature of destabilizing effects of sucrose. J. Pharm. Sci. 88:360.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lee, G. (2002). Spray-Drying of Proteins. In: Carpenter, J.F., Manning, M.C. (eds) Rational Design of Stable Protein Formulations. Pharmaceutical Biotechnology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0557-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0557-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5131-3
Online ISBN: 978-1-4615-0557-0
eBook Packages: Springer Book Archive